Episode Details

AlphaNooner reports from Virginia at the midpoint of the DEA's administrative hearing on federal cannabis rescheduling. We share what we've seen and heard inside the proceedings so far, including expert testimony from Harvard psychobiology professor Dr. Bertha Madras on addiction and the case being made against rescheduling.

We walk through the key arguments on the record, from how cannabis differs from traditional FDA-approved medicines and the history of cannabis as medicine, to claims about impacts on adolescents and mental health, and what's coming next as the hearing continues toward its scheduled close.

AlphaNooner by AdvisorShares brings you timely conversations with investors, market strategists, portfolio managers and industry experts on markets, investment themes and the stories shaping what comes next.

Watch the full video on YouTube: https://www.youtube.com/watch?v=Qlq4iNxwiCA

Follow AdvisorShares (@advisorshares) on YouTube, X, LinkedIn, Instagram and Facebook.